Psoriasis risk spikes with anti-TNF use in children with inflammatory diseases

Children with either inflammatory bowel disease, chronic noninfectious osteomyelitis or juvenile idiopathic arthritis developed psoriasis at an increased rate compared with the general public, with the highest rates seen among those treated with TNF inhibitors, according to data published in Arthritis Care & Research.“The incidence rate (IR) and risk factors of psoriasis in children with IBD, JIA or CNO who are exposed to TNF inhibitors are unknown,” Lisa H. Buckley, MD, of the Children’s Hospital of Philadelphia, and colleagues wrote. “Additionally, there is aRead More

Share on facebook
Share on twitter
Share on linkedin